BUZZ - BrightSpring shares hit a three-month high after raising its 2026 revenue forecast

October 30 - ** The share price of home healthcare provider BrightSpring Health (BTSG.O) hit a three-month high, last trading at $66.22, up 10%

** If the stock price remains at the current level, the company is poised for its largest single-day gain since May 2025

** The company has once again raised its full-year revenue guidance for fiscal 2026, from the previous range of $15.1 billion to $15.43 billion, now to $15.9 billion to $16.13 billion

** At the same time, the forecast for adjusted EBITDA in 2026 has been raised from $820 million - $845 million to $850 million - $860 million

** According to data compiled by London Stock Exchange Group (LSEG), the company reported third-quarter revenue of $4.21 billion, surpassing analysts' estimates of $3.88 billion

** Adjusted quarterly earnings per share were $0.54, also beating the expected $0.47 per share

** The company stated that demand for its specialty and infusion pharmacy services was strong, home healthcare volumes increased, and the acquired branch businesses continued to expand

** BTSG's price-to-earnings ratio (based on expected earnings for the next 12 months) is 27.07, compared to Option Care Health (OPCH.O) at 15.77 and Addus HomeCare (ADUS.O) at 16.68

** Including the gains from today, BTSG's year-to-date rise has exceeded 78%, outperforming the S&P 400 Healthcare Providers Index (.SPMDCHCPS), which is up 11%

(To assist non-English speakers, Reuters has automated the translation of its report into several other languages. Because automated translations may contain inaccuracies or lack necessary context, Reuters does not guarantee the accuracy of this translated text and provides it solely for the convenience of readers. Reuters accepts no responsibility for any loss or damage arising from the use of automated translation.)